313 related articles for article (PubMed ID: 22401750)
41. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
Hallgren H; Gustafsson I; Ripa T
Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
[No Abstract] [Full Text] [Related]
42. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases.
Marchaim D; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Sprecher H; Lachish T; Wiener-Well Y; Alon D; Chowers M; Ciobotaro P; Bardenstein R; Paz A; Potasman I; Giladi M; Schechner V; Schwaber MJ; Klarfeld-Lidji S; Carmeli Y
Antimicrob Agents Chemother; 2010 Dec; 54(12):5099-104. PubMed ID: 20837757
[TBL] [Abstract][Full Text] [Related]
43. Extended-spectrum beta-lactamases and clinical outcomes: current data.
Ramphal R; Ambrose PG
Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
[TBL] [Abstract][Full Text] [Related]
44. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N
J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a brazilian hospital.
Tuon FF; Bianchet LC; Penteado-Filho SR
Rev Soc Bras Med Trop; 2010; 43(4):452-4. PubMed ID: 20802948
[TBL] [Abstract][Full Text] [Related]
47. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
48. [Evolution of Enterobacteriaceae resistance to antibiotics in Reunion Island: emergence of extended-spectrum beta-lactamases].
Belmonte O; Drouet D; Alba J; Moiton MP; Kuli B; Lugagne-Delpon N; Mourlan C; Jaffar-Bandjee MC
Pathol Biol (Paris); 2010 Feb; 58(1):18-24. PubMed ID: 19864085
[TBL] [Abstract][Full Text] [Related]
49. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
50. Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender.
Shah AA; Hasan F; Ahmed S; Hameed A
New Microbiol; 2002 Jul; 25(3):363-6. PubMed ID: 12173781
[TBL] [Abstract][Full Text] [Related]
51. [Evolution of third-generation cephalosporin resistance in Enterobacteriaceae from 2000 to 2008 in a Perpignan hospital].
Mayoral G; Ferreyra M; Eden A; Gueudet P; Miquel C; Lecaillon E
Pathol Biol (Paris); 2010 Feb; 58(1):7-10. PubMed ID: 19854588
[TBL] [Abstract][Full Text] [Related]
52. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
[TBL] [Abstract][Full Text] [Related]
53. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
[TBL] [Abstract][Full Text] [Related]
54. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
[TBL] [Abstract][Full Text] [Related]
55. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
56. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
[TBL] [Abstract][Full Text] [Related]
57. Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.
Rodríguez-Baño J; Navarro MD
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():104-10. PubMed ID: 18154533
[TBL] [Abstract][Full Text] [Related]
58. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.
Qureshi ZA; Paterson DL; Peleg AY; Adams-Haduch JM; Shutt KA; Pakstis DL; Sordillo E; Polsky B; Sandkovsky G; Bhussar MK; Doi Y
Clin Microbiol Infect; 2012 Sep; 18(9):887-93. PubMed ID: 21951551
[TBL] [Abstract][Full Text] [Related]
60. Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand .
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jan; 29(1):80-2. PubMed ID: 18171194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
